Request For Information - contractor-managed medical services to administer the COVID-19 vaccination and monoclonal antibody (mAb) treatments

The Federal Emergency Management Agency (FEMA) is seeking to find information for contractor-managed medical services to administer the COVID-19 vaccination and monoclonal antibody (mAb) treatments. Personnel needed for these services are not limited to doctors, nurses, or paramedics but to all healthcare professionals that are certified to administer the COVID-19 vaccine or mAb treatments. These services will need to be provided as needed in areas located throughout the United States and its Territories/Insular Islands (American Samoa, Guam, Commonwealth of Northern Mariana Islands, Republic of the Marshall Islands, Federal States of Micronesia, Puerto Rico, and US Virgin Islands). In accordance with Federal Acquisition Regulation (FAR) 10.002(b)(2)(i) this notice is issued for the purpose of market research. This request is for planning purposes only and does not constitute a solicitation or an indication the government will issue a contract for the services contained in this notice. This notice is not to be construed as an acquisition Request for Proposal (RFP), nor is any commitment on the part of the government to award a contract implied, nor does the government intend to pay for any information submitted as a result of this request. The government does not reimburse respondents for any cost associated with submission of the information being requested or reimburse expenses incurred to interested parties for responses to this notice. Any response received will not be used as a proposal. FEMA is not, at this time, seeking proposals and will not accept unsolicited proposals. Please provide your capability statement and responses to the questions below. 1.Please provide the following company profile information: a. Point of Contact Name b. Address c. Telephone Number d. Email Address e. Company's Business Size f. Current / previous state or federal contracts in the past 5 years 2. Please indicate the level of support your company can provide: a. 50% of the Continental United States (CONUS), b. 100% CONUS, c. Outside the Continental United States (OCONUS) territories / commonwealth locations 3. Total number of personnel capable of administering the COVID-19 vaccine/delivering monoclonal antibody treatment? 4. How many personnel can be provided within forty-eight (48) hours? 5. How many personnel can be provided within ninety-six (96) hours? 6. How do you validate personnel are currently licensed and certified? ** WE ARE NOT ACCEPTING ANY PHONE CALLS** Please submit responses not to exceed five pages (Font type shall be Times New Roman size 12 point. No reduction of font size will be allowed. Each side of a single sheet of double-sided text is considered a page, such that a single sheet of 8 - x 11, is two pages of the page total, exclusive of dividers and any single sheet front or back cover). Please submit responses to: Sharon Edwards at sharon.edwards3@fema.dhs.gov and Erich Ducote at erich.ducote@fema.dhs.gov . All responses are due no later than Wednesday 8/3/2022 at 12:00 PM EST.